 | • レポートコード：QYR9ST03164 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、114ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、乳がん治療法の世界市場について調査・分析し、乳がん治療法の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（有糸分裂阻害剤、代謝産物、ホルモン受容体、アロマターゼ阻害剤、HER2阻害剤）、用途別（病院用、研究用）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の乳がん治療法市場動向 ・主要企業別マーケットシェア ・乳がん治療法の種類別市場規模2014-2019 （有糸分裂阻害剤、代謝産物、ホルモン受容体、アロマターゼ阻害剤、HER2阻害剤） ・乳がん治療法の用途別市場規模2014-2019 （病院用、研究用） ・乳がん治療法の北米市場：主要企業・種類別/用途別市場規模 ・乳がん治療法のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・乳がん治療法の中国市場：主要企業・種類別/用途別市場規模 ・乳がん治療法の日本国内市場：主要企業・種類別/用途別市場規模 ・乳がん治療法の東南アジア市場：主要企業・種類別/用途別市場規模 ・乳がん治療法のインド市場：主要企業・種類別/用途別市場規模 ・乳がん治療法の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Bayer HealthCare、Eli Lily、Pfizer、Novartis、Eisai、Halozyme Therapeutics、Roche、Puma Biotechnology、Janssen Biotech、AbbVie、BioMarin、Array BioPharma、Merck、Syndax、MacroGenics、ImmunoGen、Santen Pharma、Celgene、Oncothyreon、AstraZeneca、Sprint Bioscience、Genentech、Galena Biopharma、Lycera、CTI BioPharma） ・乳がん治療法の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Breast cancer is cancer that forms in the cells of the breasts.Breast cancer is cancer that develops from breast tissue. Signs of breast cancer may include a lump in the breast, a change in breast shape, dimpling of the skin, fluid coming from the nipple, a newly inverted nipple, or a red or scaly patch of skin. In those with distant spread of the disease, there may be bone pain, swollen lymph nodes, shortness of breath, or yellow skin.In 2018, the global Breast Cancer Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Breast Cancer Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Breast Cancer Therapeutics development in United States, Europe and China.
The key players covered in this study
Bayer HealthCare
Eli Lily
Pfizer
Novartis
Eisai
Halozyme Therapeutics
Roche
Puma Biotechnology
Janssen Biotech
AbbVie
BioMarin
Array BioPharma
Merck
Syndax
MacroGenics
ImmunoGen
Santen Pharma
Celgene
Oncothyreon
AstraZeneca
Sprint Bioscience
Genentech
Galena Biopharma
Lycera
CTI BioPharma
Market segment by Type, the product can be split into
Mitotic Inhibitors
Anti-Metabolites
Hormone Receptor
Aromatase Inhibitors
HER2 Inhibitors
Market segment by Application, split into
Hospital
Research
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Breast Cancer Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Breast Cancer Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Breast Cancer Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Breast Cancer Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Mitotic Inhibitors
1.4.3 Anti-Metabolites
1.4.4 Hormone Receptor
1.4.5 Aromatase Inhibitors
1.4.6 HER2 Inhibitors
1.5 Market by Application
1.5.1 Global Breast Cancer Therapeutics Market Share by Application (2014-2025)
1.5.2 Hospital
1.5.3 Research
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Breast Cancer Therapeutics Market Size
2.2 Breast Cancer Therapeutics Growth Trends by Regions
2.2.1 Breast Cancer Therapeutics Market Size by Regions (2014-2025)
2.2.2 Breast Cancer Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Breast Cancer Therapeutics Market Size by Manufacturers
3.1.1 Global Breast Cancer Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Breast Cancer Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Breast Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Breast Cancer Therapeutics Key Players Head office and Area Served
3.3 Key Players Breast Cancer Therapeutics Product/Solution/Service
3.4 Date of Enter into Breast Cancer Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Breast Cancer Therapeutics Market Size by Type (2014-2019)
4.2 Global Breast Cancer Therapeutics Market Size by Application (2014-2019)
5 United States
5.1 United States Breast Cancer Therapeutics Market Size (2014-2019)
5.2 Breast Cancer Therapeutics Key Players in United States
5.3 United States Breast Cancer Therapeutics Market Size by Type
5.4 United States Breast Cancer Therapeutics Market Size by Application
6 Europe
6.1 Europe Breast Cancer Therapeutics Market Size (2014-2019)
6.2 Breast Cancer Therapeutics Key Players in Europe
6.3 Europe Breast Cancer Therapeutics Market Size by Type
6.4 Europe Breast Cancer Therapeutics Market Size by Application
7 China
7.1 China Breast Cancer Therapeutics Market Size (2014-2019)
7.2 Breast Cancer Therapeutics Key Players in China
7.3 China Breast Cancer Therapeutics Market Size by Type
7.4 China Breast Cancer Therapeutics Market Size by Application
8 Japan
8.1 Japan Breast Cancer Therapeutics Market Size (2014-2019)
8.2 Breast Cancer Therapeutics Key Players in Japan
8.3 Japan Breast Cancer Therapeutics Market Size by Type
8.4 Japan Breast Cancer Therapeutics Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Breast Cancer Therapeutics Market Size (2014-2019)
9.2 Breast Cancer Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Breast Cancer Therapeutics Market Size by Type
9.4 Southeast Asia Breast Cancer Therapeutics Market Size by Application
10 India
10.1 India Breast Cancer Therapeutics Market Size (2014-2019)
10.2 Breast Cancer Therapeutics Key Players in India
10.3 India Breast Cancer Therapeutics Market Size by Type
10.4 India Breast Cancer Therapeutics Market Size by Application
11 Central & South America
11.1 Central & South America Breast Cancer Therapeutics Market Size (2014-2019)
11.2 Breast Cancer Therapeutics Key Players in Central & South America
11.3 Central & South America Breast Cancer Therapeutics Market Size by Type
11.4 Central & South America Breast Cancer Therapeutics Market Size by Application
12 International Players Profiles
12.1 Bayer HealthCare
12.1.1 Bayer HealthCare Company Details
12.1.2 Company Description and Business Overview
12.1.3 Breast Cancer Therapeutics Introduction
12.1.4 Bayer HealthCare Revenue in Breast Cancer Therapeutics Business (2014-2019)
12.1.5 Bayer HealthCare Recent Development
12.2 Eli Lily
12.2.1 Eli Lily Company Details
12.2.2 Company Description and Business Overview
12.2.3 Breast Cancer Therapeutics Introduction
12.2.4 Eli Lily Revenue in Breast Cancer Therapeutics Business (2014-2019)
12.2.5 Eli Lily Recent Development
12.3 Pfizer
12.3.1 Pfizer Company Details
12.3.2 Company Description and Business Overview
12.3.3 Breast Cancer Therapeutics Introduction
12.3.4 Pfizer Revenue in Breast Cancer Therapeutics Business (2014-2019)
12.3.5 Pfizer Recent Development
12.4 Novartis
12.4.1 Novartis Company Details
12.4.2 Company Description and Business Overview
12.4.3 Breast Cancer Therapeutics Introduction
12.4.4 Novartis Revenue in Breast Cancer Therapeutics Business (2014-2019)
12.4.5 Novartis Recent Development
12.5 Eisai
12.5.1 Eisai Company Details
12.5.2 Company Description and Business Overview
12.5.3 Breast Cancer Therapeutics Introduction
12.5.4 Eisai Revenue in Breast Cancer Therapeutics Business (2014-2019)
12.5.5 Eisai Recent Development
12.6 Halozyme Therapeutics
12.6.1 Halozyme Therapeutics Company Details
12.6.2 Company Description and Business Overview
12.6.3 Breast Cancer Therapeutics Introduction
12.6.4 Halozyme Therapeutics Revenue in Breast Cancer Therapeutics Business (2014-2019)
12.6.5 Halozyme Therapeutics Recent Development
12.7 Roche
12.7.1 Roche Company Details
12.7.2 Company Description and Business Overview
12.7.3 Breast Cancer Therapeutics Introduction
12.7.4 Roche Revenue in Breast Cancer Therapeutics Business (2014-2019)
12.7.5 Roche Recent Development
12.8 Puma Biotechnology
12.8.1 Puma Biotechnology Company Details
12.8.2 Company Description and Business Overview
12.8.3 Breast Cancer Therapeutics Introduction
12.8.4 Puma Biotechnology Revenue in Breast Cancer Therapeutics Business (2014-2019)
12.8.5 Puma Biotechnology Recent Development
12.9 Janssen Biotech
12.9.1 Janssen Biotech Company Details
12.9.2 Company Description and Business Overview
12.9.3 Breast Cancer Therapeutics Introduction
12.9.4 Janssen Biotech Revenue in Breast Cancer Therapeutics Business (2014-2019)
12.9.5 Janssen Biotech Recent Development
12.10 AbbVie
12.10.1 AbbVie Company Details
12.10.2 Company Description and Business Overview
12.10.3 Breast Cancer Therapeutics Introduction
12.10.4 AbbVie Revenue in Breast Cancer Therapeutics Business (2014-2019)
12.10.5 AbbVie Recent Development
12.11 BioMarin
12.12 Array BioPharma
12.13 Merck
12.14 Syndax
12.15 MacroGenics
12.16 ImmunoGen
12.17 Santen Pharma
12.18 Celgene
12.19 Oncothyreon
12.20 AstraZeneca
12.21 Sprint Bioscience
12.22 Genentech
12.23 Galena Biopharma
12.24 Lycera
12.25 CTI BioPharma
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Breast Cancer Therapeutics Key Market Segments
Table Key Players Breast Cancer Therapeutics Covered
Table Global Breast Cancer Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Breast Cancer Therapeutics Market Size Market Share by Type 2014-2025
Figure Mitotic Inhibitors Figures
Table Key Players of Mitotic Inhibitors
Figure Anti-Metabolites Figures
Table Key Players of Anti-Metabolites
Figure Hormone Receptor Figures
Table Key Players of Hormone Receptor
Figure Aromatase Inhibitors Figures
Table Key Players of Aromatase Inhibitors
Figure HER2 Inhibitors Figures
Table Key Players of HER2 Inhibitors
Table Global Breast Cancer Therapeutics Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospital Case Studies
Figure Research Case Studies
Figure Breast Cancer Therapeutics Report Years Considered
Table Global Breast Cancer Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Breast Cancer Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Breast Cancer Therapeutics Market Size by Regions 2014-2025 (Million US$)
Table Global Breast Cancer Therapeutics Market Size by Regions 2014-2019 (Million US$)
Table Global Breast Cancer Therapeutics Market Share by Regions 2014-2019
Figure Global Breast Cancer Therapeutics Market Share by Regions 2014-2019
Figure Global Breast Cancer Therapeutics Market Share by Regions 2019
Table Market Top Trends
Table Global Breast Cancer Therapeutics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Breast Cancer Therapeutics Market Share by Manufacturers (2014-2019)
Figure Global Breast Cancer Therapeutics Market Share by Manufacturers in 2018
Table Global Breast Cancer Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Breast Cancer Therapeutics Product/Solution/Service
Table Date of Enter into Breast Cancer Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Breast Cancer Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Breast Cancer Therapeutics Market Size Share by Type (2014-2019)
Figure Global Breast Cancer Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Breast Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Breast Cancer Therapeutics Market Size Share by Application (2014-2019)
Figure Global Breast Cancer Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Breast Cancer Therapeutics Revenue Market Share by Application in 2018
Figure United States Breast Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table United States Key Players Breast Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table United States Key Players Breast Cancer Therapeutics Market Share (2018-2019)
Table United States Breast Cancer Therapeutics Market Size by Type (2014-2019) (Million US$)
Table United States Breast Cancer Therapeutics Market Share by Type (2014-2019)
Table United States Breast Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table United States Breast Cancer Therapeutics Market Share by Application (2014-2019)
Figure Europe Breast Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Breast Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Breast Cancer Therapeutics Market Share (2018-2019)
Table Europe Breast Cancer Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Europe Breast Cancer Therapeutics Market Share by Type (2014-2019)
Table Europe Breast Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Europe Breast Cancer Therapeutics Market Share by Application (2014-2019)
Figure China Breast Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Breast Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Breast Cancer Therapeutics Market Share (2018-2019)
Table China Breast Cancer Therapeutics Market Size by Type (2014-20189) (Million US$)
Table China Breast Cancer Therapeutics Market Share by Type (2014-2019)
Table China Breast Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table China Breast Cancer Therapeutics Market Share by Application (2014-2019)
Figure Japan Breast Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Breast Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Breast Cancer Therapeutics Market Share (2018-2019)
Table Japan Breast Cancer Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Japan Breast Cancer Therapeutics Market Share by Type (2014-2019)
Table Japan Breast Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Japan Breast Cancer Therapeutics Market Share by Application (2014-2019)
Figure Southeast Asia Breast Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Breast Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Breast Cancer Therapeutics Market Share (2018-2019)
Table Southeast Asia Breast Cancer Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Breast Cancer Therapeutics Market Share by Type (2014-2019)
Table Southeast Asia Breast Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Breast Cancer Therapeutics Market Share by Application (2014-2019)
Figure India Breast Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Breast Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Breast Cancer Therapeutics Market Share (2018-2019)
Table India Breast Cancer Therapeutics Market Size by Type (2014-2019) (Million US$)
Table India Breast Cancer Therapeutics Market Share by Type (2014-2019)
Table India Breast Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table India Breast Cancer Therapeutics Market Share by Application (2014-2019)
Figure Central & South America Breast Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Breast Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Breast Cancer Therapeutics Market Share (2018-2019)
Table Central & South America Breast Cancer Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Breast Cancer Therapeutics Market Share by Type (2014-2019)
Table Central & South America Breast Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Breast Cancer Therapeutics Market Share by Application (2014-2019)
Table Bayer HealthCare Company Details
Table Bayer HealthCare Revenue in Breast Cancer Therapeutics Business (2014-2019) (Million US$)
Figure Bayer HealthCare Revenue Growth Rate in Breast Cancer Therapeutics Business (2014-2019)
Table Bayer HealthCare Recent Development
Table Eli Lily Company Details
Table Eli Lily Revenue in Breast Cancer Therapeutics Business (2014-2019)(Million US$)
Figure Eli Lily Revenue Growth Rate in Breast Cancer Therapeutics Business (2014-2019)
Table Eli Lily Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Breast Cancer Therapeutics Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Breast Cancer Therapeutics Business (2014-2019)
Table Pfizer Recent Development
Table Novartis Company Details
Table Novartis Revenue in Breast Cancer Therapeutics Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Breast Cancer Therapeutics Business (2014-2019)
Table Novartis Recent Development
Table Eisai Company Details
Table Eisai Revenue in Breast Cancer Therapeutics Business (2014-2019)(Million US$)
Figure Eisai Revenue Growth Rate in Breast Cancer Therapeutics Business (2014-2019)
Table Eisai Recent Development
Table Halozyme Therapeutics Company Details
Table Halozyme Therapeutics Revenue in Breast Cancer Therapeutics Business (2014-2019)(Million US$)
Figure Halozyme Therapeutics Revenue Growth Rate in Breast Cancer Therapeutics Business (2014-2019)
Table Halozyme Therapeutics Recent Development
Table Roche Company Details
Table Roche Revenue in Breast Cancer Therapeutics Business (2014-2019)(Million US$)
Figure Roche Revenue Growth Rate in Breast Cancer Therapeutics Business (2014-2019)
Table Roche Recent Development
Table Puma Biotechnology Company Details
Table Puma Biotechnology Revenue in Breast Cancer Therapeutics Business (2014-2019)(Million US$)
Figure Puma Biotechnology Revenue Growth Rate in Breast Cancer Therapeutics Business (2014-2019)
Table Puma Biotechnology Recent Development
Table Janssen Biotech Company Details
Table Janssen Biotech Revenue in Breast Cancer Therapeutics Business (2014-2019)(Million US$)
Figure Janssen Biotech Revenue Growth Rate in Breast Cancer Therapeutics Business (2014-2019)
Table Janssen Biotech Recent Development
Table AbbVie Company Details
Table AbbVie Revenue in Breast Cancer Therapeutics Business (2014-2019)(Million US$)
Figure AbbVie Revenue Growth Rate in Breast Cancer Therapeutics Business (2014-2019)
Table AbbVie Recent Development
Table BioMarin Company Details
Table Array BioPharma Company Details
Table Merck Company Details
Table Syndax Company Details
Table MacroGenics Company Details
Table ImmunoGen Company Details
Table Santen Pharma Company Details
Table Celgene Company Details
Table Oncothyreon Company Details
Table AstraZeneca Company Details
Table Sprint Bioscience Company Details
Table Genentech Company Details
Table Galena Biopharma Company Details
Table Lycera Company Details
Table CTI BioPharma Company Details
Table Global Breast Cancer Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Breast Cancer Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Breast Cancer Therapeutics Market Size Share by Regions in 2025
Figure United States Breast Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Breast Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Breast Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Breast Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Breast Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Breast Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Breast Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Breast Cancer Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Breast Cancer Therapeutics Market Size by Product (2019-2025)
Figure Global Breast Cancer Therapeutics Market Size by Product in 2025
Table Global Breast Cancer Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Breast Cancer Therapeutics Market Size by Application (2019-2025)
Figure Global Breast Cancer Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
HER2陰性乳癌治療の世界市場：市場規模・現状・予測 HER2 (human epidermal growth factor receptor 2) is a protein that appears on the surface of some breast cancer cells. It may also be called HER2/neu or ErbB2.HER2-negative breast cancer means that the people have little or no HER2 protein.In 2018, the global HER2-negative breast cancer Treatment mar…- 頭頸部癌治療薬の世界市場：市場規模・現状・予測 Head and neck cancer is a group of cancers that starts in the mouth, nose, throat, larynx, sinuses, or salivary glands. Current trends indicate that rising geriatric population worldwide, growing cases of target diseases, and availability of improved healthcare services due to government and private…
- 頭頸部癌治療薬の世界市場：市場規模・現状・予測 Head and neck cancer is a group of cancers that starts in the mouth, nose, throat, larynx, sinuses, or salivary glands. Current trends indicate that rising geriatric population worldwide, growing cases of target diseases, and availability of improved healthcare services due to government and private…
- 免疫チェックポイント阻害剤の世界市場：市場規模・現状・予測 Check point inhibitors are molecules that use the cosmic potential of the immune response system of the body, and its limitless influences to attack the cancer cells present inside the body, as well as avoids relapse of cancer cells. In case any relapse occurs in the body, it can easily be recognize…
- 乳がんモノクローナル抗体の世界市場：市場規模・現状・予測 Breast cancer is characterized by the malignancy of cells in the tissues of the breast. HER-2 breast cancer is the most common type of breast cancer. The HER-2 protein, present on the surface of normal breast cells, affects the growth of the malignant cells. The uncontrolled synthesis of this protei…